Галагудза М. М., Нифонтов Е. М., Сыренский А. В., Егорова Е. И., Блохин И. О. ВЛИЯНИЕ ИНГИБИТОРОВ АНГИОТЕНЗИН-ПРЕВРАЩАЮЩЕГО ФЕРМЕНТА ЗОФЕНОПРИЛА И КАПТОПРИЛА НА ВЫРАЖЕННОСТЬ РАННИХ ИШЕМИЧЕСКИХ ЖЕЛУДОЧКОВЫХ ТАХИАРИТМИЙ ПРИ ЭКСПЕРИМЕНТАЛЬНОМ ИНФАРКТЕ МИОКАРДА. Вестник аритмологии. 2006;(44):35-39.
1. Петрищев Н.Н., Шляхто Е.В., Власов Т.Д., Eалагудза М.М. Ишемическая адаптация миокарда: патофизиологические механизмы и возможные перспективы практического применения (обзор литературы) // Росс, физиол. журнал им. И.М.Сеченова. -2001. -Т. 87. - С. 688-705.
2. Шляхто Е.В., EалагудзаМ.М., Сыренский А.В., Нифонтов Е.М. Кардиопротективные эффекты феномена ишемического посткондиционирования миокарда // Кардиология. - 2005. - Т. 45. - С. 44-48.
3. Cascio W.E. Myocardial ischemia: what factors determine arrhythmogenesis? // J. Cardiovasc. Electrophysiol. - 2001. Vol. 12.-P 726-729.
4. Curtis M.J., Pugsley M.K., Walker M.J.A. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease// Cardiovasc. Res. -1993. - Vol. 27. -P 703-719.
5. Fonarow G.C., Chelimsky-Fallick C., Stevenson L.W. et al. Effect of direct vasodilation with hydralazine versus angiotensin converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial // J. Am. Coll. Cardiol. -1992. - Vol. 19. - P 842-850.
6. Gilat E., Girouard S.D., Pastore J.M. et al. Angiotensinconverting enzyme inhibition produces electrophysiologic but not antiarrhythmic effects in the intact heart // J. Cardiovasc. Pharmacol. -1998. - Vol. 31. - P 734-740.
7. Grassi G., Seravalle G., Bertinieri G., Mancia G. Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias // Acta Physiol. Scand. - 2003. - Vol. 177.-P 399-404.
8. Hattori Y., Atsushi S., Hiroaki R5 Toyama J. Effects of cilazapril on ventricular arrhythmia in patients with congestive heart failure // Clin. Then -1997. - Vol. 19. - P 481-486.
9. Huikuri H.V., Castellanos A., Myerburg R. J. Sudden death due to cardiac arrhythmias // N. Engl. J. Med. - 2001. - Vol. 345.-P 1473-1482.
10. Janse M.J. A brief history of sudden cardiac death and its therapy // Pharmacol. Therap. - 2003. - Vol. 100. - R 89- 99.
11. Janse M. J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resuming from myocardial ischemia and infarction//Physiol. Rev. -1989. - Vol. 69. - P 1049-1169.
12. Lynch J., Stump G.L., Wallace A.A. et al. EXP3174, the All antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction//J. Am. Coll. Cardiol. -1999. - Vol. 34. -P 876-884.
13. O’Keefe J.H., Wetzel M., Мое R.R. et al. Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? // J. Am. Coll. Cardiol.-2001.-Vol. 37.-P 1-8.
14. Ozer M.K., Sahna E., Birincioglu M., Acet A. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats // Pharmacol. Res. -2002.-Vol. 45.-P 112-119.
15. Parratt J. Endogenous myocardial protective (antiarrhythmic) substances // Cardiovasc. Res. -1993. - Vol. 27. -P.693-702.
16. Shah A.D., Arora R.R. Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors? // Clin. Cardiol. - 2005. -Vol. 28.-P 551-555.
17. Subissi A., Evangelista S., Giachetti A. Preclinical profile of zofenopril: an angiotensin converting enzyme inhibitor with peculiar cardioprotective properties // Cardiovasc. DrugRev.-1999.-Vol. 17.-P 115-133.
18. Walker M. J., Curtis M. J., Hearse D. J. et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion // Cardiovasc. Res. 1988.-Vol. 22.-P 447-455.
19. Wang L. ACE inhibitors suppress ischemia-induced arrhythmias by reducing the spatial dispersion of ventricular repolarization// Cardiology. -1999. - Vol. 92. - P 106-109.
20. Zhu B., Sun Y., Sievers R.E. et al. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion // J. Am. Coll. Cardiol. - 2000. - Vol. 35. - P 787-795.
